BullFrog AI (BFRG) surges 122% on new commercial agreement with top-5 global pharma
BullFrog AI Holdings, Inc. (BFRG) is up 122.4% today. Here is some analysis on what might have caused this price movement.
Analysis: The move appears driven by BullFrog AI’s announcement of a new commercial agreement with a top-5 global pharmaceutical company to use its platform to identify and prioritize a therapeutic target in major depressive disorder. For a micro-cap name that has recently disclosed Nasdaq listing compliance challenges, a high-profile commercial deal can be interpreted as third-party validation and a potential step toward improved business momentum.
Details:
Sources:
BullFrog AI Investor Relations, U.S. SEC (EDGAR)
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$BFRG Hedge Fund Activity
We have seen 11 institutional investors add shares of $BFRG stock to their portfolio, and 6 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DRW SECURITIES, LLC added 102,062 shares (+inf%) to their portfolio in Q4 2025, for an estimated $90,100
- ANSON FUNDS MANAGEMENT LP removed 80,750 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $71,286
- J.W. COLE ADVISORS, INC. removed 22,050 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $30,869
- HRT FINANCIAL LP added 18,799 shares (+inf%) to their portfolio in Q4 2025, for an estimated $16,595
- GEODE CAPITAL MANAGEMENT, LLC added 17,100 shares (+30.7%) to their portfolio in Q4 2025, for an estimated $15,095
- VIRTU FINANCIAL LLC added 15,287 shares (+inf%) to their portfolio in Q4 2025, for an estimated $13,495
- UBS GROUP AG added 8,075 shares (+113.8%) to their portfolio in Q4 2025, for an estimated $7,128
To track hedge funds’ stock portfolios, check out Quiver Quantitative’s institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative’s disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
